ArticleEJNMMI research2025

A prospective, multi-centre trial of PSMA-PET compared to FDG-PET for staging of newly diagnosed high risk prostate cancer.

Matthew J Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.